Cited by 811Health Systems, Economic Evaluations, Quality of LifeEconomic and Environmental ValuationPharmaceutical Economics and Policy

The DOI matches its Crossref record; 183 of the 184 references it cites were found in a registry or an index.

Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report

Open access

Ramsey, Scott D., Willke, Richard J., Glick, Henry, Reed, Shelby D., Augustovski, Federico, Jonsson, Bengt, Briggs, Andrew, Sullivan, Sean D.·2015·Value in Health

DOI 10.1016/j.jval.2015.02.001

Open this paper in CoChat — free account

Abstract

Clinical trials evaluating medicines, medical devices, and procedures now commonly assess the economic value of these interventions. The growing number of prospective clinical/economic trials reflects both widespread interest in economic information for new technologies and the regulatory and reimbursement requirements of many countries that now consider evidence of economic value along with clinical efficacy. As decision makers increasingly demand evidence of economic value for health care interventions, conducting high-quality economic analyses alongside clinical studies is desirable because they broaden the scope of information available on a particular intervention, and can efficiently provide timely information with high internal and, when designed and analyzed properly, reasonable external validity. In 2005, ISPOR published the Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force report. ISPOR initiated an update of the report in 2014 to include the methodological developments over the last 9 years. This report provides updated recommendations reflecting advances in several areas related to trial design, selecting data elements, database design and management, analysis, and reporting of results. Task force members note that trials should be designed to evaluate effectiveness (rather than efficacy) when possible, should include clinical outcome measures, and should obtain health resource use and health state utilities directly from study subjects. Collection of economic data should be fully integrated into the study. An incremental analysis should be conducted with an intention-to-treat approach, complemented by relevant subgroup analyses. Uncertainty should be characterized. Articles should adhere to established standards for reporting results of cost-effectiveness analyses. Economic studies alongside trials are complementary to other evaluations (e.g., modeling studies) as information for decision makers who consider evidence of economic value along with clinical efficacy when making resource allocation decisions.

Integrity signals

Registry

Crossref · 10.1016/j.jval.2015.02.001

Cites

183 of 183 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,385
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
World Development indicators
Awais, A. (2015) · Data Archiving and Networked Services (DANS) · doi:10.17632/zcvgc6m58h.1 · Cited by 6,790
Statistical Analysis With Missing Data
Ghosh, S., Little, R. J. A., & Rubin, D. B. (1988) · Technometrics · doi:10.2307/1269814 · Cited by 4,730
Untitled work
(1997) · doi:10.1097/00005650-199711000-00002 · Cited by 4,544

Show all 184 references

Research works printed but not linked: 2

Sullivan, 2001, Design and analytic considerations in determining the cost-effectiveness of early intervention in asthma from a multinational clinical trial, Control Clin Trials, 22, 420, 10.1016/S0197-2456(01)00137-4 · DOI
Barber, 2000, Analysis of cost data in randomized trials: an application of the nonparametric bootstrap, Stat Med, 19, 3219, 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P · DOI

Sorted by citations

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E. W., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Value in Health · doi:10.1016/j.jval.2021.11.1351 · Cited by 1,204
Self-citation
Developing and evaluating digital interventions to promote behavior change in health and health care: recommendations resulting from an international workshop
Michie, S., Yardley, L., West, R., Patrick, K., & Greaves, F. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.7126 · Cited by 865
“However, existing economic approaches (eg, ISPOR guidance [29]) will need to be adapted to take into account the way digital health interventions are delivered, covering the whole life cycle of the intervention.”
Background
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Value in Health · doi:10.1016/j.jval.2021.10.008 · Cited by 847
Self-citation
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E. W., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · BMJ · doi:10.1136/bmj-2021-067975 · Cited by 534
Self-citation
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · BMC Medicine · doi:10.1186/s12916-021-02204-0 · Cited by 450
Self-citation
Effect of a Community Health Worker–Led Multicomponent Intervention on Blood Pressure Control in Low-Income Patients in Argentina: A Randomized Clinical Trial
He, J., Irazola, V., Mills, K. T., Poggio, R., Beratarrechea, A., Dolan, J., Chen, C.-S., Gibbons, L., Krousel-Wood, M., Bazzano, L. A., et al. (2017) · JAMA · doi:10.1001/jama.2017.11358 · Cited by 241
Self-citation
Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E. W., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462321001732 · Cited by 225
Self-citation
The IDEAL framework for surgical robotics: development, comparative evaluation and long-term monitoring
Marcus, H. J., Ramirez, P. T., Khan, D. Z., Horsfall, H. L., HANRAHAN, J. G., Williams, S. C., Beard, D. J., Bhat, R. A., Catchpole, K. C., Cook, A., et al. (2024) · Nature Medicine · doi:10.1038/s41591-023-02732-7 · Cited by 213
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E. W., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Applied Health Economics and Health Policy · doi:10.1007/s40258-021-00704-x · Cited by 211
Self-citation
Comparative clinical effectiveness and cost effectiveness of endovascular strategy v open repair for ruptured abdominal aortic aneurysm: three year results of the IMPROVE randomised trial
IMPROVE Trial Investigators (2017) · BMJ · doi:10.1136/bmj.j4859 · Cited by 163
Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report
Wolowacz, S. E., Briggs, A. H., Belozeroff, V., Clarke, P., Doward, L. C., Goeree, R. A., Lloyd, A. J., & Norman, R. (2016) · Value in Health · doi:10.1016/j.jval.2016.06.001 · Cited by 167
Self-citation
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Husereau, D., Drummond, M., Augustovski, F., Briggs, A., Carswell, C., Caulley, L., Chaiyakunapruk, N., de Bekker‐Grob, E., Greenberg, D., Loder, E., et al. (2022) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17012 · Cited by 150
Self-citation
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E. W., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · MDM Policy & Practice · doi:10.1177/23814683211061097 · Cited by 159
Self-citation
Linear mixed models to handle missing at random data in trial‐based economic evaluations
Gabrio, A., Plumpton, C., Banerjee, S., & Leurent, B. (2022) · Health Economics · doi:10.1002/hec.4510 · Cited by 152
Cost‐effectiveness of emergency department‐initiated treatment for opioid dependence
Busch, S. H., Fiellin, D. A., Chawarski, M. C., Owens, P. H., Pantalon, M. V., Hawk, K. F., Bernstein, S. L., O’Connor, P. G., & D’Onofrio, G. (2017) · Addiction · doi:10.1111/add.13900 · Cited by 128
Screening and Intervention to Prevent Falls and Fractures in Older People
Lamb, S. E., Bruce, J., Hossain, A., Ji, C., Longo, R., Lall, R., Bojke, C., Hulme, C. T., Withers, E. J., Finnegan, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001500 · Cited by 127
Cost-Effectiveness of Non-Invasive and Non-Pharmacological Interventions for Low Back Pain: a Systematic Literature Review
Andronis, L., Kinghorn, P., Qiao, S., Whitehurst, D. G. T., Durrell, S., & McLeod, H. (2016) · Applied Health Economics and Health Policy · doi:10.1007/s40258-016-0268-8 · Cited by 115
“While good practice guidelines for conducting economic evaluations suggest that appraisal of interventions that are likely to affect absenteeism should include productivity costs [53, 54], there was considerable variation amongst studies in relation to the inclusion of such costs.”
Background
Blueprint for cancer research: Critical gaps and opportunities
Elmore, L. W., Greer, S. F., Daniels, E. C., Saxe, C. C., Melner, M. H., Krawiec, G. M., Cance, W. G., & Phelps, W. C. (2020) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21652 · Cited by 124
Recomendaciones para el tratamiento de los pacientes críticos de los Grupos de Trabajo de la Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC)
Hernández-Tejedor, A., Peñuelas, Ó., Sirgo, G., Llompart-Pou, J. A., Herrejon, E. P., Estella, Á., Cabanes, M. P. F., Alcalá-Llorente, M. A., Galleymore, P. R., Azuara, B. O., et al. (2017) · Medicina Intensiva · doi:10.1016/j.medin.2017.03.004 · Cited by 105
Challenges in synthesising cost-effectiveness estimates
Shields, G., & Elvidge, J. (2020) · Systematic Reviews · doi:10.1186/s13643-020-01536-x · Cited by 102
Use of Checklists in Reviews of Health Economic Evaluations, 2010 to 2018
Watts, R., & Li, I. W. (2018) · Value in Health · doi:10.1016/j.jval.2018.10.006 · Cited by 97
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E. W., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · PharmacoEconomics · doi:10.1007/s40273-021-01112-8 · Cited by 97
Self-citation
Interventions to increase attendance for diabetic retinopathy screening
Lawrenson, J. G., Graham-Rowe, E., Lorencatto, F., Burr, J. M., Bunce, C., Francis, J., Aluko, P., Rice, S. J. C., Vale, L. D., Pető, T., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012054.pub2 · Cited by 94
Designing and undertaking a health economics study of digital health interventions
McNamee, P., Murray, E., Kelly, M. P., Bojke, L., Chilcott, J., Fischer, A., West, R., & Yardley, L. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.05.007 · Cited by 82
“To enhance the conduct and reporting of trial-based economic evaluation studies applied to new medicines, medical devices, and procedures, the International Society for Pharmacoeconomics and Outcomes Research has published an updated good research practice guide.(1) This re-emphasizes the need to base economic evidenc…”
Method
Comparison of behavioural activation with guided self-help for treatment of depression in adults with intellectual disabilities: a randomised controlled trial
Jahoda, A. J., Hastings, R. P., Hatton, C., Cooper, S., Dagnan, D., Zhang, R., McConnachie, A., McMeekin, N., Appleton, K., Jones, R., et al. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30426-1 · Cited by 94
Self-citation
Early, specialist vocational rehabilitation to facilitate return to work after traumatic brain injury: the FRESH feasibility RCT
Radford, K., Sutton, C., Sach, T., Holmes, J. A., Watkins, C. L., Forshaw, D., Jones, T. M., Hoffman, K., O’Connor, R. J., Tyerman, R., et al. (2018) · Health Technology Assessment · doi:10.3310/hta22330 · Cited by 83
Are education, exercise and diet interventions a cost-effective treatment to manage hip and knee osteoarthritis? A systematic review
Mazzei, D. R., Ademola, A., Abbott, J. H., Sajobi, T., Hildebrand, K. A., & Marshall, D. A. (2020) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2020.10.002 · Cited by 83
Cost Effectiveness of Multigene Panel Sequencing for Patients With Advanced Non–Small-Cell Lung Cancer
Steuten, L., Goulart, B. H. L., Meropol, N. J., Pritchard, D. E., & Ramsey, S. D. (2019) · JCO Clinical Cancer Informatics · doi:10.1200/cci.19.00002 · Cited by 78
Self-citation
Preventing Depression in Adults With Subthreshold Depression: Health-Economic Evaluation Alongside a Pragmatic Randomized Controlled Trial of a Web-Based Intervention
Buntrock, C., Berking, M., Smit, F., Lehr, D., Nobis, S., Riper, H. M., Cuijpers, P. J., & Ebert, D. D. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.6587 · Cited by 84
“We conducted and reported the health-economic evaluation in agreement with the Consolidated Health Economic Evaluation Reporting Standards statement [17] and the guidelines from the International Society for Pharmacoeconomics and Outcomes Research [18].”
Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT
Scarborough, M., Li, H. K., Rombach, I., Zambellas, R., Walker, A. S., McNally, M., Atkins, B. L., Kümin, M., Lipsky, B. A., Hughes, H. C., et al. (2019) · Health Technology Assessment · doi:10.3310/hta23380 · Cited by 77
“5) Details on lower limb infections n = 436 n = 418 n = 854 Hip 110 (25) 104 (25) 214 (25) Knee 133 (31) 115 (27) 248 (29) Foot 89 (20) 86 (21) 175 (20) Other area of lower limb infection 105 (24) 113 (27) 218 (26) Operative findings Draining sinus arising from bone/prosthesis 177 (34) 142 (27) 319 (30) Frank pus adja…”
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E. W., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Clinical Therapeutics · doi:10.1016/j.clinthera.2022.01.011 · Cited by 77
Self-citation
Implementing economic evaluation in simulation‐based medical education: challenges and opportunities
Lin, Y., Cheng, A., Hecker, K. G., Grant, V. J., & Currie, G. R. (2017) · Medical Education · doi:10.1111/medu.13411 · Cited by 74
Research design considerations for randomized controlled trials of spinal cord stimulation for pain: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials/Institute of Neuromodulation/International Neuromodulation Society recommendations
Katz, N. P., Dworkin, R. H., North, R. B., Thomson, S., Eldabe, S. S., Hayek, S. M., Kopell, B. H., Markman, J. D., Rezai, A. R., Taylor, R. S., et al. (2021) · Pain · doi:10.1097/j.pain.0000000000002204 · Cited by 74
Effectiveness and cost-effectiveness of daily all-over-body application of emollient during the first year of life for preventing atopic eczema in high-risk children (The BEEP trial): protocol for a randomised controlled trial
Chalmers, J. R., Haines, R., Mitchell, E. J., Thomas, K. S., Brown, S., Ridd, M. J., Lawton, S., Simpson, E. L., Cork, M. J., Sach, T., et al. (2017) · Trials · doi:10.1186/s13063-017-2031-3 · Cited by 73
Paraplegia prevention in aortic aneurysm repair by thoracoabdominal staging with ‘minimally invasive staged segmental artery coil embolisation’ (MIS²ACE): trial protocol for a randomised controlled multicentre trial
Petroff, D., Czerny, M., Kölbel, T., Melissano, G., Lönn, L., Haunschild, J., von ASPERN, K., Neuhaus, P., Pelz, J. O., Epstein, D. M., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025488 · Cited by 74
“Bootstrap methods will be used to characterise uncertainty.(26) Further details will be provided in a statistical analysis plan.”
BackgroundMethod
The statistical approach in trial-based economic evaluations matters: get your statistics together!
Mutubuki, E. N., Alili, M. E., Bosmans, J. E., Oosterhuis, T., Snoek, F. J., Ostelo, R., van Tulder, M. W., & van Dongen, J. M. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-06513-1 · Cited by 72
Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus Survey
Thorn, J. C., Davies, C. F., Brookes, S. T., Noble, S. M., Dritsaki, M., Gray, E., Hughes, D. A., Mihaylova, B., Petrou, S., Ridyard, C., et al. (2021) · Value in Health · doi:10.1016/j.jval.2020.10.002 · Cited by 70
“Prespecified analysis plans have been used in other areas of economics(6); however, guidance on preparing HEAPs for economic evaluations conducted alongside RCTs and their appropriate content is currently sparse.(7) HEAPs are rarely published; the few examples are typically standalone appendices(8) or part of a SAP,(9…”
Home‐based pulmonary rehabilitation for COPD using minimal resources: An economic analysis
Burge, A. T., Holland, A. E., McDonald, C. F., Abramson, M. J., Hill, C. J., Lee, A. L., Cox, N. S., Moore, R., Nicolson, C., O’Halloran, P., et al. (2019) · Respirology · doi:10.1111/resp.13667 · Cited by 68
Cost-effectiveness of prehabilitation prior to elective surgery: a systematic review of economic evaluations
Rombey, T., Eckhardt, H., Kiselev, J., Silzle, J., Mathes, T., & Quentin, W. (2023) · BMC Medicine · doi:10.1186/s12916-023-02977-6 · Cited by 67
Social Media and Obesity in Adults: a Review of Recent Research and Future Directions
Waring, M. E., Jake‐Schoffman, D. E., Holovatska, M. M., Mejia, C., Williams, J. C., & Pagoto, S. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1001-9 · Cited by 67
Recommendations on Robotic Hepato-Pancreato-Biliary Surgery. The Paris Jury-Based Consensus Conference
Hobeika, C., Pfister, M., Geller, D. A., Tsung, A., Chan, A. C. Y., Troisi, R. I., Rela, M., Benedetto, F. D., Sucandy, I., Nagakawa, Y., et al. (2024) · Annals of Surgery · doi:10.1097/sla.0000000000006365 · Cited by 66
“The jury considered that pragmatic study designs with formal economic evaluations providing trial-based comparative cost-effectiveness analyses 201,202 should be prioritized in these situations (Table 4).”
A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent
Mant, D., Gray, A. M., Pugh, S. A., Campbell, H., George, S., Fuller, A., Shinkins, B., Corkhill, A., Mellor, J., Dixon, E. L., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21320 · Cited by 66
The effectiveness of high molecular weight hyaluronic acid for knee osteoarthritis in patients in the working age: a randomised controlled trial
Hermans, J., Bierma‐Zeinstra, S., Bos, P. K., Niesten, D. D., Verhaar, J. A. N., & Reijman, M. (2019) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-019-2546-8 · Cited by 64
A cost-effectiveness analysis of freeze-only or fresh embryo transfer in IVF of non-PCOS women
Khoa, L. D., Vuong, L. N., Ho, T. M., Dang, V. Q., Pham, T. D., Pham, C. T., Norman, R. J., & Mol, B. W. (2018) · Human Reproduction · doi:10.1093/humrep/dey253 · Cited by 62
Systematic review of economic evaluations for internet- and mobile-based interventions for mental health problems
Kählke, F., Buntrock, C., Smit, F., & Ebert, D. D. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00702-w · Cited by 66
The Socioeconomic Impact of Irritable Bowel Syndrome: An Analysis of Direct and Indirect Health Care Costs
Bosman, M., Weerts, Z. Z. R. M., Snijkers, J. T. W., Vork, L., Mujagic, Z., Masclee, A., Jonkers, D. M. A. E., & Keszthelyi, D. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.01.017 · Cited by 62
Is telehealthcare for heart failure patients cost-effective? An economic evaluation alongside the Danish TeleCare North heart failure trial
Vestergaard, A. S., Hansen, L., Sørensen, S. S., Jensen, M. B., & Ehlers, L. H. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-031670 · Cited by 60
“19 Thus, a particular strength of this study was the micro-costing approach, including the availability of information on patient-specific resource usage from the Danish registers.”
Measurement tools of resource use and quality of life in clinical trials for dementia or cognitive impairment interventions: A systematically conducted narrative review
Yang, F. B., Dawes, P., Leroi, I., & Gannon, B. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4771 · Cited by 60
Cost-effectiveness of telehealthcare to patients with chronic obstructive pulmonary disease: results from the Danish ‘TeleCare North’ cluster-randomised trial
Udsen, F. W., Lilholt, P. H., Hejlesen, O. K., & Ehlers, L. H. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014616 · Cited by 60
“Current good practise for trial-based economic evaluation recommends that analyses should account for missing data by imputation, especially when there is a large amount of missing data.(41) The applied imputation procedure followed the principles recommended by Faria et al.”
Cost-Effectiveness of Supplemental Donor Milk Versus Formula for Very Low Birth Weight Infants
Trang, S., Zupancic, J. A. F., Unger, S. L., Kiss, A., Bando, N., Wong, S. E., Gibbins, S., O’Connor, D. L., & on behalf of the GTA DoMINO Feeding Group (2018) · PEDIATRICS · doi:10.1542/peds.2017-0737 · Cited by 60
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: Updated reporting guidance for health economic evaluations
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E. W., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Health Policy OPEN · doi:10.1016/j.hpopen.2021.100063 · Cited by 64
Self-citation
Assessing the potential cost-effectiveness of a gene therapy for the treatment of hemophilia A
Cook, K., Forbes, S. P., Adamski, K. N., Janice, J., Chawla, A., & Garrison, L. P. (2020) · Journal of Medical Economics · doi:10.1080/13696998.2020.1721508 · Cited by 58
Self-reported and routinely collected electronic healthcare resource-use data for trial-based economic evaluations: the current state of play in England and considerations for the future
Franklin, M. K., & Thorn, J. C. (2019) · BMC Medical Research Methodology · doi:10.1186/s12874-018-0649-9 · Cited by 57
Optimizing psychotherapy dosage for comorbid depression and personality disorders (PsyDos): a pragmatic randomized factorial trial using schema therapy and short-term psychodynamic psychotherapy
Kool, M., Van, H. L., Bartak, A., de Maat, S. C. M., Arntz, A. R., van den Eshof, J. W., Peen, J., Blankers, M., Bosmans, J. E., & Dekker, J. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1829-1 · Cited by 60
A health economic outcome evaluation of an internet-based mobile-supported stress management intervention for employees
Ebert, D. D., Kählke, F., Buntrock, C., Berking, M., Smit, F., Heber, E., Baumeister, H., Funk, B., Riper, H. M., & Lehr, D. (2017) · Scandinavian Journal of Work Environment & Health · doi:10.5271/sjweh.3691 · Cited by 62
A multifaceted implementation strategy versus passive implementation of low back pain guidelines in general practice: a cluster randomised controlled trial
Riis, A., Jensen, C. E., Bro, F., Maindal, H. T., Petersen, K. D., Bendtsen, M. D., & Jensen, M. B. (2016) · Implementation Science · doi:10.1186/s13012-016-0509-0 · Cited by 55
“The evaluation was carried out as a within-trial assessment with a 12-week time horizon [14].”
Method
General population normative data for the EQ-5D-3L in the five largest European economies
Janssen, M. F., Pickard, A. S., & Shaw, J. W. (2021) · The European Journal of Health Economics · doi:10.1007/s10198-021-01326-9 · Cited by 55
Cost-Effectiveness of Tenecteplase Before Thrombectomy for Ischemic Stroke
Gao, L., Moodie, M., Mitchell, P. J., Churilov, L. P., Kleinig, T. J., Yassi, N., Yan, B., Parsons, M. W., Donnan, G. A., Davis, S. M., et al. (2020) · Stroke · doi:10.1161/strokeaha.120.029666 · Cited by 55
The Polyanalgesic Consensus Conference (PACC)®: Intrathecal Drug Delivery Guidance on Safety and Therapy Optimization When Treating Chronic Noncancer Pain
Deer, T. R., Hayek, S. M., Grider, J. S., Hagedorn, J. M., McDowell, G. C., II, Kim, P., Dupoiron, D., Goel, V., Duarte, R. V., Pilitsis, J. G., et al. (2024) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2024.03.003 · Cited by 57
Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluation
Pooran, A., Theron, G., Zijenah, L. S., Chanda, D. M., Clowes, P., Mwenge, L., Mutenherwa, F., Leccese, P. A., Metcalfe, J. Z., Sohn, H., et al. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30164-0 · Cited by 54
Comparing alternating pressure mattresses and high-specification foam mattresses to prevent pressure ulcers in high-risk patients: the PRESSURE 2 RCT
Nixon, J., Brown, S. T., Smith, I. L., McGinnis, E., Vargas‐Palacios, A., Nelson, E. A., Brown, J. M., Coleman, S. B., Collier, H., Fernandez, C., et al. (2019) · Health Technology Assessment · doi:10.3310/hta23520 · Cited by 53
Health Economic and Safety Considerations for Artificial Intelligence Applications in Diabetic Retinopathy Screening
Xie, Y., Gunasekeran, D. V., Balaskas, K., Keane, P. A., Sim, D. A., Bachmann, L. M., Macrae, C., & Ting, D. S. W. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.2.22 · Cited by 59
Health care costs and resource utilization for different asthma severity stages in Colombia: a claims data analysis
Flórez-Tanus, Á., Padilla, D. P., Zakzuk, J., Caraballo, L. R., & Alvis‐Guzmán, N. (2018) · World Allergy Organization Journal · doi:10.1186/s40413-018-0205-4 · Cited by 52
“The International Society of Pharmacoeconomics and Outcomes Research – ISPOR good research practice guidelines were used for cost data analysis [42].”
Method
Economic evaluation of an implementation strategy for the management of low back pain in general practice
Jensen, C. E., Riis, A., Petersen, K. D., Jensen, M. B., & Pedersen, K. M. (2017) · Pain · doi:10.1097/j.pain.0000000000000851 · Cited by 50
“Furthermore, statistical analyses were conducted on the basis of intention-to-treat and in accordance with current guidelines on conducting economic evaluations alongside clinical trials.(34)”
Method
Time and resources of peripherally inserted central catheter insertion procedures: a comparison between blind insertion/chest X-ray and a real time tip navigation and confirmation system
Tomaszewski, K. J., Ferko, N. C., Hollmann, S., Eng, S., Richard, H., Rowe, L., & Sproule, S. (2017) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s121230 · Cited by 51
The SITLESS project: exercise referral schemes enhanced by self-management strategies to battle sedentary behaviour in older adults: study protocol for a randomised controlled trial
Giné‐Garriga, M., Coll‐Planas, L., Guerra-Balic, M., Domingo, À., Figuls, M. R. I., Caserotti, P., Denkinger, M. D., Rothenbacher, D., Tully, M. A., Kee, F., et al. (2017) · Trials · doi:10.1186/s13063-017-1956-x · Cited by 54
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E. W., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · BMC Public Health · doi:10.1186/s12889-021-12491-0 · Cited by 50
Self-citation
The cost-effectiveness of exercise-based cardiac rehabilitation: a systematic review of the characteristics and methodological quality of published literature
Edwards, K., Jones, N., Newton, J. L., Foster, C. E., Judge, A., Jackson, K., Arden, N., & Pinedo‐Villanueva, R. (2017) · Health Economics Review · doi:10.1186/s13561-017-0173-3 · Cited by 49
The Current Status of EMDR Therapy, Specific Target Areas, and Goals for the Future
Matthijssen, S. J. M. A., Lee, C. W., de Roos, C., Barron, I. G., Jarero, I., Shapiro, E., Hurley, E. C., Schubert, S. J., Baptist, J., Amann, B. L., et al. (2020) · Journal of EMDR Practice and Research · doi:10.1891/emdr-d-20-00039 · Cited by 48
“Future research into the cost-effectiveness of EMDR should be guided by expert guidelines in this area such as CHEERS (Husereau et al., 2013) or the ISPOR Good Research Practices Task Force Report (Ramsey et al., 2015).”
Conducting Trial-Based Economic Evaluations Using R: A Tutorial
Ben, Â. J., van Dongen, J. M., Alili, M. E., Eßer, J., Broulíková, H. M., & Bosmans, J. E. (2023) · PharmacoEconomics · doi:10.1007/s40273-023-01301-7 · Cited by 48
Reduction of pharmaceutical expenditure by a drug appropriateness intervention in polymedicated elderly subjects in Catalonia (Spain)
Campins, L., Serra‐Prat, M., Palomera, E., Bolíbar, I., Martínez, M. À., & Gallo, P. (2017) · Gaceta Sanitaria · doi:10.1016/j.gaceta.2017.09.002 · Cited by 47
The clinical application of beta-lactam antibiotic therapeutic drug monitoring in the critical care setting
Mangalore, R. P., Peel, T. N., Udy, A. A., & Peleg, A. Y. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad223 · Cited by 49
Economic evaluation of the home blood pressure telemonitoring and pharmacist case management to control hypertension (Hyperlink) trial
Dehmer, S. P., Maciosek, M. V., Trower, N. K., Asche, S. E., Bergdall, A. R., Nyboer, R. A., O’Connor, P. J., Pawloski, P. A., Sperl‐Hillen, J. M., Green, B. B., et al. (2018) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1001 · Cited by 47
Conducting Economic Evaluations Alongside Randomised Trials: Current Methodological Issues and Novel Approaches
Hughes, D. A., Charles, J. M., Dawoud, D., Edwards, R. T., Holmes, E. A. F., Jones, C., Parham, P. E., Plumpton, C., Ridyard, C. H., Lloyd‐Williams, H., et al. (2016) · PharmacoEconomics · doi:10.1007/s40273-015-0371-y · Cited by 45
“Approaches to trial-based economic evaluation have consequently evolved, as detailed in recent guidelines and reviews [2-4].”
Economic evaluation of cognitive behavioral therapy and Internet‐based guided self‐help for binge‐eating disorder
König, H., Bleibler, F., Friederich, H., Herpertz, S., Lam, T., Mayr, A. J., Schmidt, F., Svaldi, J., Zipfel, S., Brettschneider, C., et al. (2018) · International Journal of Eating Disorders · doi:10.1002/eat.22822 · Cited by 45
“The recommended perspective for economic evaluations is the societal perspective wherein possibly all kinds of resource use are considered (Ramsey et al., 2015).”
Background
Household contact investigation for the detection of tuberculosis in Vietnam: economic evaluation of a cluster-randomised trial
Lung, T. W.-C., Marks, G. B., Nhung, N. V., Nguyen, T. A., Hoa, N. L. P., Anh, L. T. N., Hoa, N. B., Britton, W. J., Bestrashniy, J., Jan, S., et al. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30520-5 · Cited by 45
Long-term effectiveness and cost-effectiveness of an 18-week supervised exercise program in patients treated with autologous stem cell transplantation: results from the EXIST study
van Dongen, J. M., Persoon, S., Jongeneel, G., Bosmans, J. E., Kersten, M. J., Brug, J., Nollet, F., Chinapaw, M. J. M., & Buffart, L. M. (2019) · Journal of Cancer Survivorship · doi:10.1007/s11764-019-00775-9 · Cited by 45
“This is due to differences in the applied statistical methods, including (1) the use of mixed effect models in the effectiveness analyses, which are typically not applied in cost-effectiveness analyses, (2) multiple imputation, which is recommended for imputing missing cost data [26] versus maximum likelihood estimati…”
Method
Computed tomography versus invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trial
The DISCHARGE Trial Group, Napp, A. E., Haase, R., Laule, M., Schuetz, G. M., Rief, M., Dreger, H., Feuchtner, G. M., Friedrich, G. J., Špaček, M., et al. (2016) · European Radiology · doi:10.1007/s00330-016-4620-z · Cited by 44
A randomized controlled trial comparing the clinical efficacy and cost-effectiveness of eye movement desensitization and reprocessing (EMDR) and integrated EMDR-Dialectical Behavioural Therapy (DBT) in the treatment of patients with post-traumatic stress disorder and comorbid (Sub)clinical borderline personality disorder: study design
Snoek, A., Beekman, A. T. F., Dekker, J., Aarts, I., van Grootheest, G., Blankers, M., Vriend, C., van den Heuvel, O., & Thomaes, K. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02713-x · Cited by 44
“We will take into account the CHEERS statement [92] and the 2015 ISPOR good research practices task force report on cost-effectiveness analysis alongside clinical trials [93].”
Method
Efficacy of an internet-based self-help intervention to reduce co-occurring alcohol misuse and depression symptoms in adults: study protocol of a three-arm randomised controlled trial
Schaub, M. P., Blankers, M., Lehr, D., Boß, L., Riper, H. M., Dekker, J., Goudriaan, A. E., Maier, L. J., Haug, S., Amann, M., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011457 · Cited by 46
“Cost-effectiveness calculations The economic evaluation will be conducted alongside the randomised trial, taking into account the CHEERS statement(66) and the 2015 ISPOR good research practices task force report on cost-effectiveness analysis alongside clinical trials.(67) From the technical point of view, the economi…”
Method
Cost-effectiveness of deep brain stimulation versus treatment as usual for obsessive-compulsive disorder
Ooms, P., Blankers, M., Figee, M., Bergfeld, I. O., van den Munckhof, P., Schuurman, P. R., & Denys, D. A. J. P. (2017) · Brain stimulation · doi:10.1016/j.brs.2017.04.120 · Cited by 44
Economic evaluation of factorial randomised controlled trials: challenges, methods and recommendations
Dakin, H., & Gray, A. M. (2017) · Statistics in Medicine · doi:10.1002/sim.7322 · Cited by 43
“172); given that most two-arm trials are not powered to detect significant differences in mean costs or NMB [4,62] and the variance around the interaction term is four-fold higher than that for main effects [17,23], this finding is likely to be common among economic evaluations of factorial trials.”
BackgroundMethodInfluential
Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT
Batchelor, J., Millington, A., Thomas, K. S., Akram, P., Azad, J., Bewley, A., Chalmers, J. R., Cheung, S. T., Duley, L., Eleftheriadou, V., et al. (2020) · Health Technology Assessment · doi:10.3310/hta24640 · Cited by 44
“Number unblinded, n (%) 45 (39) 66 (55) 55 (44)”
Cost-utility and biological underpinnings of Mindfulness-Based Stress Reduction (MBSR) versus a psychoeducational programme (FibroQoL) for fibromyalgia: a 12-month randomised controlled trial (EUDAIMON study)
Feliu‐Soler, A., Borràs, X., Peñarrubia‐María, M. T., Rozadilla‐Sacanell, A., D’Amico, F., Moss-Morris, R. E., Howard, M. A., Fayed, N. M., Soriano‐Mas, C., Puebla‐Guedea, M., et al. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1068-2 · Cited by 46
“Gotink RA, Chu P, Busschbach JJ, Benson H, Fricchione GL, Hunink MG. Standardised mindfulness-based interventions in healthcare: an overview of systematic reviews and meta-analyses of RCTs. PLoS ONE.”
MethodInfluential
Randomised controlled trial of silk therapeutic garments for the management of atopic eczema in children: the CLOTHES trial
Thomas, K. S., Bradshaw, L. E., Sach, T., Cowdell, F., Batchelor, J., Lawton, S., Harrison, E., Haines, R., Ahmed, A. I., Dean, T., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21160 · Cited by 43
“ICERs will be calculated using accepted methodology (Ramsey et al 2015, Drummond et al 2005).”
Method
Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study
For the EVINCI Investigators, Lorenzoni, V., Bellelli, S., Caselli, C., Knuuti, J. M., Underwood, S. R., Neglia, D., & Turchetti, G. (2019) · The European Journal of Health Economics · doi:10.1007/s10198-019-01096-5 · Cited by 42
A scoping review of statistical methods for trial‐based economic evaluations: The current state of play
Alili, M. E., van Dongen, J. M., Eßer, J., Heymans, M. W., van Tulder, M. W., & Bosmans, J. E. (2022) · Health Economics · doi:10.1002/hec.4603 · Cited by 41
“Over the last decades, various recommendations have been made on how to analyze trial-based economic evaluations (Petrou & Gray, 2011; Ramsey et al., 2015; van Dongen et al., 2014).”
BackgroundMethod
Cost-effectiveness of home-based cardiac rehabilitation: a systematic review
Shields, G., Rowlandson, A., Dalal, G., Nickerson, S., Cranmer, H., Capobianco, L., & Doherty, P. (2023) · Heart · doi:10.1136/heartjnl-2021-320459 · Cited by 41
Cost-Utility of Group Acceptance and Commitment Therapy for Fibromyalgia Versus Recommended Drugs: An Economic Analysis Alongside a 6-Month Randomized Controlled Trial Conducted in Spain (EFFIGACT Study)
Luciano, J. V., D'Amico, F., Feliu-Soler, A., McCracken, L. M., Aguado, J., Peñarrubia-María, M. T., Knapp, M., Serrano-Blanco, A., & García-Campayo, J. (2017) · The Journal of Pain · doi:10.1016/j.jpain.2017.03.001 · Cited by 42
Consolidated Health Economic Evaluation Reporting Standards - Value of Information (CHEERS-VOI): Explanation and Elaboration
Kunst, N., Siu, A., Drummond, M., Grimm, S. E., Grutters, J. P. C., Husereau, D., Koffijberg, H., Rothery, C., Wilson, E., & Heath, A. (2023) · Value in Health · doi:10.1016/j.jval.2023.06.014 · Cited by 40
Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma
Berdahl, J. P., Khatana, A. K., Katz, L. J., Herndon, L. W., Layton, A. J., Yu, T. M., Bauer, M. J., & Cantor, L. B. (2017) · Journal of Medical Economics · doi:10.1080/13696998.2017.1327439 · Cited by 40
Cost-effectiveness of Antenatal Corticosteroid Therapy vs No Therapy in Women at Risk of Late Preterm Delivery
Gyamfi‐Bannerman, C., Zupancic, J. A. F., Sandoval, G. J., Grobman, W. A., Blackwell, S. C., Tita, A., Reddy, U. M., Jain, L., Saade, G. R., Rouse, D. J., et al. (2019) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2019.0032 · Cited by 38
Cost-effectiveness of adherence-enhancing interventions: a systematic review
Simon‐Tuval, T., Neumann, P. J., & Greenberg, D. (2016) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2016.1138858 · Cited by 38
“An ideal comparator is one that represents the best current or most common practice (ideally both).[66] The most common practice does not include any educational communication, thus it was reasonable to choose usual care as a comparator and conclude that these counseling strategies are cost-effective; however, it may…”
Background
Recommendations of the Working Groups from the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of adult critically ill patients
Hernández-Tejedor, A., Peñuelas, Ó., Sirgo, G., Llompart-Pou, J. A., Herrejon, E. P., Estella, Á., Cabanes, M. P. F., Alcalá-Llorente, M. A., Galleymore, P. R., Azuara, B. O., et al. (2017) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2017.03.008 · Cited by 37
Evaluating a multicomponent program to improve hypertension control in Guatemala: study protocol for an effectiveness-implementation cluster randomized trial
Paniagua-Ávila, A., Fort, M. P., Glasgow, R. E., Gulayin, P., Hernández-Galdamez, D. R., Mansilla, K., Palacios, E., Peralta-García, A., Roche, D., Rubinstein, A., et al. (2020) · Trials · doi:10.1186/s13063-020-04345-8 · Cited by 39
“We will analyze differences in costs following a similar analytical approach as that used for estimating health outcomes [32].”
Method
Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes in a low- and middle-income setting: Trial-based analysis of the Kerala Diabetes Prevention Program
Sathish, T., Oldenburg, B. F., Thankappan, K. R., Absetz, P., Shaw, J. E., Tapp, R. J., Zimmet, P., Balachandran, S., Shetty, S. S., Aziz, Z., et al. (2020) · BMC Medicine · doi:10.1186/s12916-020-01704-9 · Cited by 40
“We estimated costs from the health system and societal perspectives, in accordance with the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement [23] and cost-effectiveness analysis guidelines [24, 25].”
BackgroundMethodInfluential
Healthcare resource utilization and direct costs of transfusion-dependent thalassemia patients in Dubai, United Arab Emirates: a retrospective cost-of-illness study
Alshamsi, S., Hamidi, S., & Narcı, H. Ö. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-07663-6 · Cited by 38
A Review of Clinical Trials With an Adaptive Design and Health Economic Analysis
Flight, L., Arshad, F., Barnsley, R., Patel, K., Julious, S. A., Brennan, A., & Todd, S. (2019) · Value in Health · doi:10.1016/j.jval.2018.11.008 · Cited by 36
Evaluation of the Clinical, Technical, and Financial Aspects of Cost-Effectiveness Analysis of Artificial Intelligence in Medicine: Scoping Review and Framework of Analysis
Gomez-Rossi, J., Feldberg, B., Krois, J., & Schwendicke, F. (2022) · JMIR Medical Informatics · doi:10.2196/33703 · Cited by 39
Theory-driven group-based complex intervention to support self-management of osteoarthritis and low back pain in primary care physiotherapy: protocol for a cluster randomised controlled feasibility trial (SOLAS)
Hurley, D. A., Hall, A. M., Murphy, L., Pincus, T., Kamper, S. J., Maher, C. G., McDonough, S., Lonsdale, C., Walsh, N. E., Guérin, S., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010728 · Cited by 37
“Finally, the cost of the SOLAS intervention compared with usual PT will be calculated from the health service and societal perspectives using data from resource utilisation measures, alongside exploratory analysis of quality-adjusted life years (EQ-5D) and disease-specific measures.(85)”
Method

Authors: Ramsey, S. D., Willke, R. J., Glick, H., Reed, S. D., Augustovski, F., Jonsson, B., Briggs, A., & Sullivan, S. D.
Affiliations: University of Washington (US)
Pfizer (United States) (US)
University of Pennsylvania (US)
Duke University (US)
Universidad de Buenos Aires (AR)
University of Glasgow (GB)
Corresponding author: Ramsey, Scott D.
ORCID: Ramsey, Scott D.
Willke, Richard J.
Reed, Shelby D.
Augustovski, Federico
Briggs, Andrew
Sullivan, Sean D.
Venue: Value in Health
Publisher: Elsevier BV
Published: 2015-03
Volume: 18
Issue: 2
Pages: 161-172
ISSN: 1098-3015 (ISSN-L)
DOI: 10.1016/j.jval.2015.02.001
OpenAlex: W2139814250
Cited by: 811
References: 184
Citations by year: 2026: 58 · 2025: 75 · 2024: 90 · 2023: 80 · 2022: 100 · 2021: 103 · 2020: 88 · 2019: 65 · 2018: 50 · 2017: 57 · 2016: 37 · 2015: 6
FWCI: 17.59
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 366 d)
Locations: Value in Health (publishedVersion)
PubMed (publishedVersion)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
Topics: Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Environmental Valuation
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
Keywords: cost-effectiveness analysis, clinical trials, economic evaluation, trial design, health care utilization, health utility, intention-to-treat analysis, subgroup analysis, uncertainty characterization, reporting guidelines, reimbursement decisions, healthcare resource allocation
MeSH terms: Cost-Benefit Analysis, Health Policy, Health Services Research, Humans, Randomized Controlled Trials as Topic, Advisory Committees, Research Report

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks